top of page
All Posts
Bridging Cultivation and Compliance: Insights from the EU GACP 2025 Guideline Revision
The European medicinal cannabis industry continues to evolve rapidly, increasing the demand for harmonised quality systems and stronger regulatory oversight. The 2025 revision of the EU Good Agricultural and Collection Practice (GACP) Guideline marks a significant step forward, redefining how GACP and Good Manufacturing Practice (GMP) connect to ensure pharmaceutical-grade quality starts at cultivation. Recently, I attended the EU GACP–GMP Interface Training led by Dr Marku
Mikayla Clark
3 days ago3 min read
Enhancing Supply Chain Integrity Through Supplier and Vendor Qualification
We recently supported one of our clients in implementing a robust Supplier/Vendor Qualification process, ensuring that all external...
Mikayla Clark
Sep 251 min read
Another Licence, Another Milestone. FINA Supports Internode Pharma to Secure MS and Schedule 1 CD Licences
Internode Pharma has successfully secured both a Manufacturer’s Specials (MS) licence and a Schedule 1 Controlled Drugs licence from...
Mikayla Clark
Sep 181 min read
Quality Systems, Clinical Development & Regulatory Intelligence; building credibility, scalability and longevity in the Medicinal Cannabis Sector
When it comes to cannabis, regulation is not a barrier, but rather a business builder. In this insightful episode, Jaydon Inott, an...
mikayla9496
Aug 11 min read
bottom of page